Marktprognose für menschliche Lebermodelle im asiatisch-pazifischen Raum bis 2028 – Auswirkungen von COVID-19 und regionale Analyse nach Typ (Leberorganoide, Leber-auf-einem-Chip, 2D-Modelle, 3D-Bioprinting und andere), Anwendung (Arzneimittelentwicklung, Bildung und andere). ) und Endbenutzer (Pharma- und Biotechnologieunternehmen, Forschungsinstitute und andere)

Der APAC-Markt für menschliche Lebermodelle wird voraussichtlich von 33.191,56 Tausend US-Dollar im Jahr 2021 auf 76.341,40 Tausend US-Dollar im Jahr 2028 wachsen; Es wird geschätzt, dass es von 2021 bis 2028 mit einer jährlichen Wachstumsrate von 12,6 % wachsen wird.\\n\\nChina, Japan, Indien, Südkorea und Australien sind wichtige Volkswirtschaften in APAC. Es wird erwartet, dass die zunehmende Konzentration auf Arzneimittelforschungsaktivitäten das Marktwachstum ankurbeln wird. Bevor ein neues Medikament in einer klinischen Studie getestet wird, erfolgt die Hauptphasenanalyse der Pharmakodynamik und Pharmakokinetik anhand von Tiermodellen und zweidimensionalen (2D) In-vitro-Modellen. Es dauert 1215 Jahre und 35 Milliarden US-Dollar, um ein einziges Medikament auf den Markt zu bringen. Die steigende Nachfrage nach neuen und fortschrittlichen Arzneimitteln treibt das allgemeine Tempo der Arzneimittelforschung und -entdeckung voran. Infolgedessen werden zahlreiche klinische Studien durchgeführt, um neue Medikamente zu entwickeln und zu vermarkten. Auch nach der Markteinführung (Phase IV) kommt es immer noch zu zahlreichen Medikamentenentnahmen aus toxikologischen Gründen. Etwa 1830 % dieser Entzugserscheinungen sind auf hepatotoxische Wirkungen zurückzuführen, was zeigt, dass die Leber das häufigste Ziel unerwünschter Arzneimittelwirkungen (UAW) ist. Die Leber spielt eine entscheidende Rolle beim Arzneimittelstoffwechsel, der Körperhomöostase, der Verdauung und der Ausscheidung toxischer Substanzen. Im Fall der Leber sind isolierte subzelluläre Fraktionen wie Mikrosomen, die Arzneimittel metabolisierende Enzyme (DMEs) oder isolierte Mitochondrien enthalten, die einfachsten Modelle für die Wirkstoffentwicklung. Um eine hohe Sensitivität und Spezifität zu ermöglichen, müssen die zellbasierten Modelle Arzneimittelprozesse höherer Ordnung reproduzieren [dh Biotransformation, Transportkinetik, Sekundärmetabolitenbildung und Arzneimittelinteraktionen (DDIs)]. Menschliche Lebermodelle werden zur Beurteilung des Metabolismus und der Toxizität chemischer Verbindungen und Arzneimittel sowie zur Beurteilung von Arzneimittelkandidaten in der Krebsforschung und in genetischen Studien verwendet. Es wird erwartet, dass die deutliche Zunahme klinischer Studien die Nachfrage nach fortschrittlichen medizinischen Technologien, einschließlich Organoidmodellen, ankurbeln und damit das Wachstum des APAC-Marktes vorantreiben wird.\\n\\nDie biopharmazeutische Industrie in APAC war im Jahr 2020 während des Ausbruchs von COVID-19 einige Monate lang gestört . Aufgrund der COVID-19-Pandemie wurden klinische Studien aufgrund von Beschränkungen zur Eindämmung der Infektionsausbreitung unterbrochen. Aufgrund der steigenden Nachfrage nach Produkten zur Behandlung der COVID-19-Infektion konzentrierten sich die biopharmazeutischen und pharmazeutischen Unternehmen in Indien und China jedoch weiterhin auf Forschungsaktivitäten. Beispielsweise ging Vir Biotechnology (USA) im Februar 2020 eine Partnerschaft mit WuXi Biologics (China) ein, um menschliche monoklonale Antikörper zur Behandlung von COVID-19-Infektionen zu entwickeln. Diese Partnerschaft umfasst die klinische Entwicklung, Herstellung und Vermarktung, und WuXi Biologics wird für die Prozess- und Formulierungsentwicklung sowie die frühe Produktion für die klinische Entwicklung verantwortlich sein. Darüber hinaus haben Unternehmen in der Region ihre Kernaktivitäten auf Eis gelegt, um sich auf die Entwicklung des COVID-19-Impfstoffs zu konzentrieren. Beispielsweise ging das Biotech-CRO Novotech (Australien) im März 2020 eine Partnerschaft mit Komipharm International (Südkorea) ein, um klinische Studien mit Panaphix als potenzielle Behandlung für COVID-19 durchzuführen. Die jüngsten Beschränkungen, die viele Länder als Reaktion auf den COVID-19-Ausbruch verhängt haben, haben Auswirkungen auf die laufende klinische Forschung. \\n\\nMit den neuen Funktionen und Technologien können Anbieter neue Kunden gewinnen und ihre Präsenz in Schwellenmärkten erweitern. Dieser Faktor dürfte den APAC-Markt für menschliche Lebermodelle antreiben. Es wird erwartet, dass der APAC-Markt für menschliche Lebermodelle im Prognosezeitraum mit einer guten jährlichen Wachstumsrate wachsen wird. \\n\\nAPAC-Markt für menschliche Lebermodelle Umsatz und Prognose bis 2028 (in Tausend US-Dollar) \\n\\nAPAC-Markt für menschliche Lebermodelle Segmentierung \\nAPAC-Markt für menschliche Lebermodelle nach Typ\\n- Leberorganoide\\n- Leber auf einem Chip \\n- 2D-Modelle\\n- 3D-Bioprinting\\n- Andere\\nAPAC-Markt für menschliche Lebermodelle nach Anwendung\\n- Arzneimittelforschung\\n- Bildung\\n- Andere\\nAPAC-Markt für menschliche Lebermodelle nach Endbenutzer\\n- Pharmazeutik und Biotechnologie Unternehmen\\n- Forschungsinstitute \\n- Andere \\nAPAC Human Liver Models Market, nach Land\\n- Japan \\n- China\\n- Indien\\n- Südkorea \\n- Australien\\n- Rest von APAC\\nAPAC Human Liver Models Market -Erwähnte Unternehmen \\n- BioIVT\\n- CELLINK\\n- CYFUSE BIOMEDICAL KK\\n- Emulate, Inc.\\n- InSphero\\n- Kerafast\\n- MIMETAS BV\\n- THERMO FISHER SCIENTIFIC INC.\\n\\ N

TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 APAC Human Liver Models Market By Type
1.3.2 APAC Human Liver Models Market By Application
1.3.3 APAC Human Liver Models Market By End User
1.3.4 APAC Human Liver Models Market By Country
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. APAC Human Liver Models Market Market Landscape
4.1 Overview
4.2 APAC PEST Analysis
4.3 Experts Opinion
5. APAC Human Liver Models Market Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Prevalence of Liver Diseases
5.1.2 Growing Focus on Developing Alternatives for Animal Testing Models
5.2 Market Restraints
5.2.1 High Costs of Liver Models
5.3 Market Opportunities
5.3.1 Increasing focus on Drug Discovery Activities
5.4 Future Trends
5.4.1 Technology Advancements in Organ Printing
5.1 Impact analysis
6. Human Liver Models Market APAC Analysis
6.1 APAC Human Liver Models Market Revenue Forecast and Analysis
7. APAC Human Liver Models Market Analysis By Type
7.1 Overview
7.2 APAC Human Liver Models Market Revenue Share, by Type (2021 and 2028)
7.3 Liver Organoids
7.3.1 Overview
7.3.2 Liver Organoids: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
7.4 Liver-on-a-chip
7.4.1 Overview
7.4.2 Liver-on-a-chip: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
7.5 2D Models
7.5.1 Overview
7.5.2 2D Models: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
7.6 3D Bioprinting
7.6.1 Overview
7.6.2 3D Bioprinting: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
7.7 Others
7.7.1 Overview
7.7.2 Others: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
8. APAC Human Liver Models Market Analysis By Application
8.1 Overview
8.2 APAC Human Liver Models Market Share, by Application, 2021 and 2028, (%)
8.3 Educational
8.3.1 Overview
8.3.2 Educational: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
8.4 Drug Discovery
8.4.1 Overview
8.4.2 Drug Discovery: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
8.5 Other
8.5.1 Overview
8.5.2 Other: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
9. APAC Human Liver Models Market Analysis By End User
9.1 Overview
9.2 APAC Human Liver Models Market Share, by End User, 2021 and 2028, (%)
9.3 Research Institutes
9.3.1 Overview
9.3.2 Research Institutes: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
9.4 Pharmaceutical and Biotechnology Companies
9.4.1 Overview
9.4.2 Pharmaceutical and Biotechnology Companies: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
9.5 Others
9.5.1 Overview
9.5.2 Others: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
10. APAC Human Liver Models Market Country Analysis
10.1 APAC: Human Liver Models Market
10.1.1 Overview
10.1.2 APAC: Human Liver Models Market, by Country, 2021 & 2028 (%)
10.1.2.1 China: Human Liver Models Market Revenue and Forecast to 2028 (USD Thousand)
10.1.2.1.1 China: Human Liver Models Market Revenue and Forecast to 2028 (USD Thousand)
10.1.2.1.2 China: Human Liver Models Market, by Type, 20192028 (USD Thousand)
10.1.2.1.3 China: Human Liver Models Market, By Application, 20192028 (USD Thousand)
10.1.2.1.4 China: Human Liver Models Market, by End User, 20192028 (USD Thousand)
10.1.2.2 Japan: Human Liver Models Market Revenue and Forecast to 2028 (USD Thousand)
10.1.2.2.1 Japan: Human Liver Models Market Revenue and Forecast to 2028 (USD Thousand)
10.1.2.2.2 Japan: Human Liver Models Market, by Type, 20192028 (USD Thousand)
10.1.2.2.3 Japan: Human Liver Models Market, By Application, 20192028 (USD Thousand)
10.1.2.2.4 Japan: Human Liver Models Market, by End User, 20192028 (USD Thousand)
10.1.2.3 India: Human Liver Models Market Revenue and Forecast to 2028 (USD Thousand)
10.1.2.3.1 India: Human Liver Models Market Revenue and Forecast to 2028 (USD Thousand)
10.1.2.3.2 India: Human Liver Models Market, by Type, 20192028 (USD Thousand)
10.1.2.3.3 India: Human Liver Models Market, By Application, 20192028 (USD Thousand)
10.1.2.3.4 India: Human Liver Models Market, by End User, 20192028 (USD Thousand)
10.1.2.4 Australia: Human Liver Models Market Revenue and Forecast to 2028 (USD Thousand)
10.1.2.4.1 Australia: Human Liver Models Market Revenue and Forecast to 2028 (USD Thousand)
10.1.2.4.2 Australia: Human Liver Models Market, by Type, 20192028 (USD Thousand)
10.1.2.4.3 Australia: Human Liver Models Market, By Application, 20192028 (USD Thousand)
10.1.2.4.4 Australia: Human Liver Models Market, by End User, 20192028 (USD Thousand)
10.1.2.5 South Korea: Human Liver Models Market Revenue and Forecast to 2028 (USD Thousand)
10.1.2.5.1 South Korea: Human Liver Models Market Revenue and Forecast to 2028 (USD Thousand)
10.1.2.5.2 South Korea: Human Liver Models Market, by Type, 20192028 (USD Thousand)
10.1.2.5.3 South Korea: Human Liver Models Market, By Application, 20192028 (USD Thousand)
10.1.2.5.4 South Korea: Human Liver Models Market, by End User, 20192028 (USD Thousand)
10.1.2.6 Rest of APAC: Human Liver Models Market Revenue and Forecast to 2028 (USD Thousand)
10.1.2.6.1 Rest of APAC: Human Liver Models Market Revenue and Forecast to 2028 (USD Thousand)
10.1.2.6.2 Rest of APAC: Human Liver Models Market, by Type, 20192028 (USD Thousand)
10.1.2.6.3 Rest of APAC: Human Liver Models Market, By Application, 20192028 (USD Thousand)
10.1.2.6.4 Rest of APAC: Human Liver Models Market, by End User, 20192028 (USD Thousand)
11. Impact Of COVID-19 Pandemic on APAC Human Liver Models Market
11.1 APAC: Impact Assessment of COVID-19 Pandemic
12. Industry Landscape
12.1 Overview
12.2 Organic Developments
12.2.1 Overview
12.3 Inorganic Developments
12.3.1 Overview
13. Company Profiles
13.1 THERMO FISHER SCIENTIFIC INC.
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Emulate, Inc.
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 CYFUSE BIOMEDICAL K.K.
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 MIMETAS BV
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 InSphero
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 BioIVT
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 CELLINK
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Kerafast
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms

LIST OF TABLES
Table 1. APAC Human Liver Models Market, Revenue and Forecast, 20192028 (US$ Thousand)
Table 2. China: Human Liver Models Market, by Type Revenue and Forecast to 2028 (USD Thousand)
Table 3. China: Human Liver Models Market, By Application Revenue and Forecast to 2028 (USD Thousand)
Table 4. China: Human Liver Models Market, by End User Revenue and Forecast to 2028 (USD Thousand)
Table 5. Japan: Human Liver Models Market, by Type Revenue and Forecast to 2028 (USD Thousand)
Table 6. Japan: Human Liver Models Market, By Application Revenue and Forecast to 2028 (USD Thousand)
Table 7. Japan: Human Liver Models Market, by End User Revenue and Forecast to 2028 (USD Thousand)
Table 8. India: Human Liver Models Market, by Type Revenue and Forecast to 2028 (USD Thousand)
Table 9. India: Human Liver Models Market, By Application Revenue and Forecast to 2028 (USD Thousand)
Table 10. India: Human Liver Models Market, by End User Revenue and Forecast to 2028 (USD Thousand)
Table 11. Australia: Human Liver Models Market, by Type Revenue and Forecast to 2028 (USD Thousand)
Table 12. Australia: Human Liver Models Market, By Application Revenue and Forecast to 2028 (USD Thousand)
Table 13. Australia: Human Liver Models Market, by End User Revenue and Forecast to 2028 (USD Thousand)
Table 14. South Korea: Human Liver Models Market, by Type Revenue and Forecast to 2028 (USD Thousand)
Table 15. South Korea: Human Liver Models Market, By Application Revenue and Forecast to 2028 (USD Thousand)
Table 16. South Korea: Human Liver Models Market, by End User Revenue and Forecast to 2028 (USD Thousand)
Table 17. Rest of APAC: Human Liver Models Market, by Type Revenue and Forecast to 2028 (USD Thousand)
Table 18. Rest of APAC: Human Liver Models Market, By Application Revenue and Forecast to 2028 (USD Thousand)
Table 19. Rest of APAC: Human Liver Models Market, by End User Revenue and Forecast to 2028 (USD Thousand)
Table 20. Organic Developments Done by Companies
Table 21. Inorganic Developments Done by Companies
Table 22. Glossary of Terms

LIST OF FIGURES
Figure 1. APAC Human Liver Models Market Segmentation
Figure 2. APAC Human Liver Models Market Segmentation, By Country
Figure 3. APAC Human Liver Models Market Overview
Figure 4. Liver Organoids Held the Largest Share in 2020
Figure 5. India to Show Significant Growth During Forecast Period
Figure 6. APAC PEST Analysis
Figure 7. APAC Human Liver Models Market Impact Analysis of Drivers and Restraints
Figure 8. APAC Human Liver Models Market Revenue Forecast and Analysis
Figure 9. APAC Human Liver Models Market Revenue Share, by Type (2021 and 2028)
Figure 10. APAC Liver Organoids: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 11. APAC Liver-on-a-chip: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 12. APAC 2D Models: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 13. APAC 3D Bioprinting: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 14. APAC Others: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 15. APAC Human Liver Models Market Share, by Application, 2021 and 2028 (%)
Figure 16. APAC Educational: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 17. APAC Drug Discovery: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 18. APAC Other: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 19. APAC Human Liver Models Market Share, by End User, 2021 and 2028 (%)
Figure 20. APAC Research Institutes: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 21. APAC Pharmaceutical and Biotechnology Companies: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 22. APAC Others: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 23. APAC: Human Liver Models Market, by Key Country Revenue (2021) (USD Thousand)
Figure 24. APAC: Human Liver Models Market, by Country, 2021 & 2028 (%)
Figure 25. China: Human Liver Models Market Revenue and Forecast to 2028 (USD Thousand)
Figure 26. Japan: Human Liver Models Market Revenue and Forecast to 2028 (USD Thousand)
Figure 27. India: Human Liver Models Market Revenue and Forecast to 2028 (USD Thousand)
Figure 28. Australia: Human Liver Models Market Revenue and Forecast to 2028 (USD Thousand)
Figure 29. South Korea: Human Liver Models Market Revenue and Forecast to 2028 (USD Thousand)
Figure 30. Rest of APAC: Human Liver Models Market Revenue and Forecast to 2028 (USD Thousand)
Figure 31. Impact of COVID-19 Pandemic in APAC Country Markets

1. BioIVT
2. CELLINK
3. CYFUSE BIOMEDICAL K.K.
4. Emulate, Inc.
5. InSphero
6. Kerafast
7. MIMETAS BV
8. THERMO FISHER SCIENTIFIC INC.

- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the APAC human liver models market. - Highlights key business priorities in order to assist companies to realign their business strategies - The key findings and recommendations highlight crucial progressive industry trends in the APAC human liver models market, thereby allowing players across the value chain to develop effective long-term strategies - Develop/modify business expansion plans by using substantial growth offering developed and emerging markets - Scrutinize in-depth APAC market trends and outlook coupled with the factors driving the human liver models market, as well as those hindering it - Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement
Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports

Report Name	Published Date
Asia Pacific Wind Turbine Condition Monitoring Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Component (Hardware, and Software an..	May 2022
Asia Pacific Automotive System Simulation Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Transmission, Engine, Elec..	May 2022
Asia Pacific Ground Engaging Tools Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Application (Excavators, Loaders, Bulldozers, an..	May 2022

Purchase Options

Single User License

$3000

$1800

Site License

$4000

$2400

Enterprise License

$5000

$3000

GET FREE SAMPLE PDF

Inquire before Buying Inquire for Discount

Subscription Member Price: FREE

Get Subscription

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

Request for Free Sample